Avior Wealth Management’s Generation Bio GBIO Stock Holding History

Avior Wealth Management’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1	Closed	-$36	–	2828
2024 Q1	$36	Buy	+1	New	+$24	﹤0.01%	3567

Other funds holding GBIO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Avior Wealth Management's GBIO Position: Q2 2024 in Review

Avior Wealth Management sold out of Generation Bio (GBIO) in Q2 2024, closing a stake of 1 share — an estimated $36 sold.

Avior Wealth Management first reported a position in GBIO in Q1 2024 and held it in 1 quarter. The position peaked at $36 in Q1 2024. 77 funds tracked by Wall St. Rank hold GBIO as of Q2 2024.

Avior Wealth Management reported no remaining Generation Bio position as of Q2 2024 after selling out during the quarter.
Avior Wealth Management sold 1 Generation Bio share in Q2 2024, an estimated $36.
Avior Wealth Management first reported a position in Generation Bio in Q1 2024 and held it in 1 quarter.
Avior Wealth Management's Generation Bio position peaked at $36 in Q1 2024.
77 funds tracked by Wall St. Rank held Generation Bio as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.